Scott R. Serels
Director of daily operations which involve urodyna
Urology
Bladder Control Center of Norwalk
United States of America
Biography
Dr. Serels graduated Magna Cum Laude from Brandeis University in 1988 with a B.A. in both biology and economics. He then completed his medical degree at New York University School of Medicine in 1992 where he was the recipient of the Samuel Soifer Memorial Award. He completed his urologic residency at Albert Einstein College of Medicine and Montefiore Medical Center in New York. While in residency, he studied at both Memorial Sloan Kettering hospital for urologic oncology and at UCLA for urogynecology. He was recognized for his outstanding clinical work during this time by receiving an award from Montefiore Medical Center
Research Interest
Female Urology, Neurourology and voiding dysfunction for both Males and Females.
Publications
-
Karram MM, Toglia MR, Serels SR, Andoh M, Fakhoury A, Forero-Schwanhaeuser S. Treatment with solifenacin increases warning time and improves symptoms of overactive bladder: results from VENUS, a randomized, double-blind, placebo-controlled trial. Urology. 2009 Jan 31;73(1):14-8.
-
Moore RD, Serels SR, Davila GW. Minimally invasive treatment for female stress urinary incontinence. Expert Review of Obstetrics & Gynecology. 2008 Mar 1;3(2):257-72.
-
Toglia MR, Serels SR, Laramee C, Karram MM, Nandy IM, Andoh M, Seifeldin R, Sergio FS. Solifenacin for overactive bladder: patient-reported outcomes from a large placebo-controlled trial. Postgraduate medicine. 2009 Sep 1;121(5):151-8.
